Daniel Storey

2.0k total citations
9 papers, 125 citations indexed

About

Daniel Storey is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Daniel Storey has authored 9 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Genetics and 2 papers in Surgery. Recurrent topics in Daniel Storey's work include Microscopic Colitis (7 papers), Inflammatory Bowel Disease (7 papers) and Eosinophilic Esophagitis (2 papers). Daniel Storey is often cited by papers focused on Microscopic Colitis (7 papers), Inflammatory Bowel Disease (7 papers) and Eosinophilic Esophagitis (2 papers). Daniel Storey collaborates with scholars based in United Kingdom, Netherlands and Malaysia. Daniel Storey's co-authors include Sreedhar Subramanian, Paul Flanagan, Philip J Smith, Martyn Dibb, Susanna Dodd, Alan Steel, Paul Collins, C Probert, Ajay Verma and Michael Davies and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Arthritis Care & Research.

In The Last Decade

Daniel Storey

8 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Storey United Kingdom	4	108	90	54	23	12	9	125
Sofie Berg United States	7	140 1.3×	112 1.2×	46 0.9×	51 2.2×	9 0.8×	21	154
Giulia Rizzuto Italy	7	159 1.5×	130 1.4×	27 0.5×	37 1.6×	9 0.8×	13	169
An Outtier Belgium	6	149 1.4×	102 1.1×	60 1.1×	54 2.3×	10 0.8×	22	178
Luisa de Castro Spain	6	160 1.5×	133 1.5×	25 0.5×	54 2.3×	7 0.6×	9	176
Sharmayne Farrior United States	3	145 1.3×	85 0.9×	68 1.3×	27 1.2×	12 1.0×	5	154
Rosalba Orlando Italy	7	148 1.4×	109 1.2×	22 0.4×	80 3.5×	8 0.7×	11	175
Katherine Hanigan Australia	6	111 1.0×	74 0.8×	29 0.5×	48 2.1×	3 0.3×	20	131
Vishal Patel United States	5	109 1.0×	101 1.1×	19 0.4×	31 1.3×	18 1.5×	11	158
James Izanec United States	7	90 0.8×	67 0.7×	21 0.4×	59 2.6×	7 0.6×	23	128
Costantino Zampaletta Italy	8	115 1.1×	111 1.2×	22 0.4×	67 2.9×	8 0.7×	15	166

Countries citing papers authored by Daniel Storey

Since Specialization

Citations

This map shows the geographic impact of Daniel Storey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Storey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Storey more than expected).

Fields of papers citing papers by Daniel Storey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Storey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Storey. The network helps show where Daniel Storey may publish in the future.

Co-authorship network of co-authors of Daniel Storey

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Storey. A scholar is included among the top collaborators of Daniel Storey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Storey. Daniel Storey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Collins, Amy, Erik Ramon‐Gil, Daniel Geh, et al.. (2025). Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screening. Hepatology Communications. 9(6). 1 indexed citations

Smith, Philip J, Daniel Storey, Andrew Kneebone, et al.. (2022). Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. Journal of Crohn s and Colitis. 16(9). 1436–1446. 54 indexed citations

Smith, Philip J, Daniel Storey, Andrew Kneebone, et al.. (2022). 405: EFFICACY AND SAFETY OF ELECTIVE SWITCHING OF INFLAMAMTORY BOWEL DISEASE PATIENTS FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY. Gastroenterology. 162(7). S–89.

Smith, Philip J, Daniel Storey, Andrew Kneebone, et al.. (2021). PMO-16 Efficacy and safety of elective switching from intravenous to subcutaneous infliximab: A multi-centre cohort study. A84.1–A84. 2 indexed citations

Dodd, Susanna, Daniel Storey, Michael Davies, et al.. (2020). Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease. Alimentary Pharmacology & Therapeutics. 52(8). 1341–1352. 43 indexed citations

Subramanian, Sreedhar, Susanna Dodd, Daniel Storey, et al.. (2019). P423 Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S321–S321. 1 indexed citations

Davies, Michael, Daniel Storey, Christopher Watters, et al.. (2019). P586 Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: a multi-centre retrospective cohort study. Journal of Crohn s and Colitis. 13(Supplement_1). S407–S408. 2 indexed citations

Davis, Rebecca J., Susanna Dodd, Daniel Storey, et al.. (2019). Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis. European Journal of Gastroenterology & Hepatology. 31(6). 661–667. 12 indexed citations

Boers, Maarten, Frank Buttgereit, Kenneth G. Saag, et al.. (2015). What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?. Arthritis Care & Research. 67(9). 1202–1209. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact